When used as an alternative source of drugs to treat inflammation‐associated diseases,
phytochemicals with anti‐inflammatory properties provide beneficial impacts. Galangin is …

Dose-limiting toxicities (DLTs) are severe adverse effects that define the maximum tolerated
dose of a cancer drug. In addition to the specific mechanisms of each drug, common …

Low-dose methotrexate (MTX) is a standard therapy for rheumatoid arthritis due to its low
cost and efficacy. Despite these benefits, MTX has been reported to cause chronic drug …

Cardiac toxicity is a public health issue that can be caused by both environmental and
occupational exposures. The current study aimed to investigate the effectiveness of …

Methotrexate (MTX) is a chemotherapeutic agent widely used to treat a variety of tumors.
Nonetheless, MTX‐induced hippocampal neurotoxicity is a well‐defined dose‐limiting …

Doxorubicin (DOX), which is frequently used in cancer treatment, has limited clinical use due
to adverse effects on healthy tissues, especially the liver. Therefore, it is necessary to …

Methotrexate is a chemotherapy medication frequently used to treat various forms of cancer.
The purpose of this research was to examine if the administration of Arthrospira platensis …

Objectives Methotrexate (MTX) is an antimetabolite agent widely used to manage a variety
of tumors and autoimmune diseases. Nonetheless, MTX-induced intestinal intoxication is a …

Intestinal injury is a common adverse effect of methotrexate (MTX) therapy, limiting its
clinical use. Despite oxidative stress and inflammation being the most embedded …

Methotrexate (MTX) is one of the most widely used cytotoxic chemotherapeutic agents, and it
is used in the treatment of different autoimmune disorders. However, the clinical applications …